Research location
Hamelin
Germany
Advertisement
Research activity in Hamelin
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 23 trials and 24 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hamelin
23 linked trials · page 1 of 1NeoRad Breast Cancer StudyNCT04261244 · 2024-02-01 · 1 site observation
RECRUITING
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect ManagementNCT05362760 · 2022-04-27 · 1 site observation
RECRUITING
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NASTNCT04101851 · 2021-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.NCT04767594 · 2020-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaNCT02471404 · 2015-09-21 · 1 site observation
COMPLETED
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast CancerNCT02474641 · 2015-06-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyNCT02173769 · 2014-06-01 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's DiseaseNCT00752388 · 2008-11-01 · 1 site observation
COMPLETED
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation
TERMINATED
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal WomenNCT00545077 · 2007-11-06 · 1 site observation
COMPLETED
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinNCT01152606 · 2007-08-30 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaNCT00540163 · 2007-04-01 · 1 site observation
COMPLETED
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer PatientsNCT00798070 · 2007-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 2 site observations
COMPLETED
Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast CancerNCT00375752 · 2006-06-01 · 1 site observation
TERMINATED
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerNCT00332852 · 2006-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesNCT00605020 · 2003-12-02 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.